Related Experiment Video
Updated: Feb 5, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients
Veronica Balatti1,2, Luisa Tomasello1,2, Laura Z Rassenti3
1Department of Cancer Biology and Medical Genetics and.
Insights
Specific microRNAs, miR-125a-5p and miR-34a-5p, can predict Richter syndrome in chronic lymphocytic leukemia (CLL) patients. These microRNA biomarkers may guide treatment strategies for CLL and Richter syndrome.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia, marked by CD19+/CD5+ lymphocyte accumulation.
- Richter syndrome (RS) is a fatal complication of CLL, transforming into aggressive B-cell lymphomas with no predictive tests.
- MicroRNA dysregulation is implicated in cancer development and progression.
Purpose of the Study:
- To investigate if specific microRNA expression levels can predict the development of Richter syndrome in CLL patients.
- To identify potential microRNA biomarkers for predicting RS in CLL.
Main Methods:
- MicroRNA expression profiling was performed on samples from 49 CLL patients who developed RS and 59 CLL patients who did not.
- Comparative analysis of microRNA expression levels between the RS and non-RS CLL patient groups.
Main Results:
- High expression of miR-125a-5p (approx. 20-fold increase) or low expression of miR-34a-5p (approx. 21-fold decrease) was observed in CLL patients who developed RS.
- These microRNA expression patterns predicted approximately 50% of RS cases with a low false positive rate of about 9%.
Conclusions:
- miR-125a-5p and miR-34a-5p serve as valuable predictive markers for Richter syndrome in CLL.
- These microRNAs may offer crucial information for tailoring therapeutic strategies in CLL patients, potentially impacting RS development.
Abstract:
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. It is characterized by the accumulation of CD19+/CD5+ lymphocytes and can have variable outcomes. Richter syndrome (RS) is a lethal complication in CLL patients that results in aggressive B-cell lymphomas, and there are no tests to predict its occurrence. Because alterations in microRNA expression can predict the development and progression of several cancers, we investigated whether dysregulation of specific microRNAs can predict RS in CLL patients. Thus, we compared microRNA expression levels in samples from 49 CLL patients who later developed RS with samples from 59 CLL patients who did not. We found that high expression of miR-125a-5p or low expression of miR -34a-5p can predict ∼50% of RS with a false positive rate of ∼9%. We found that CLL patients predicted to develop RS show either an increase of miR-125a-5p expression (∼20-fold) or a decrease of miR-34a-5p expression (∼21-fold) compared with CLL patients that are not predicted to develop RS. Thus, miR-125a-5p and miR-34a-5p can be valuable predictor markers of RS and have the potential to provide physicians with information that can indicate the best therapeutic strategy for CLL patients.
Related Concept Videos
Predicting Molecular Geometry
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Predicting Reaction Outcomes

